Skip to Content
Merck
All Photos(1)

Documents

Y0001383

Homatropine methylbromide for system suitability

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Homatropine methylbromide, Homatropine methobromide

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C17H24BrNO3
CAS Number:
80-49-9
Molecular Weight:
370.28
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

homatropine

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

InChI

1S/C17H24NO3.BrH/c1-18(2)13-8-9-14(18)11-15(10-13)21-17(20)16(19)12-6-4-3-5-7-12;/h3-7,13-16,19H,8-11H2,1-2H3;1H/q+1;/p-1

InChI key

FUFVKLQESJNNAN-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Homatropine methylbromide for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

S-N Wang et al.
Journal of clinical pathology, 59(11), 1196-1199 (2006-10-31)
Hepatic angiomyolipoma (AML), a rare benign mesenchymal tumour, is characterised by the presence of mature adipose tissue, smooth-muscle cells and thick-walled blood vessels. Increasing attention to hepatic AMLs has led to the discovery that sufficient proportions of fat often allow
Pier Paolo Bassareo et al.
European journal of pediatrics, 170(12), 1569-1575 (2011-08-05)
Reflex vagal hypertonia (RVH) has been identified as a possible cause of sudden unexpected death in infants during the first year of life. Homatropine methylbromide (HM) is an anticholinergic drug known to inhibit muscarinic acetylcholine receptors, thus affecting the parasympathetic
Faten Limaiem et al.
Acta gastro-enterologica Belgica, 75(4), 443-445 (2013-02-14)
Hepatic angiomyolipoma (HAML) is a rare, benign mesenchymal neoplasm composed of varying amounts of smooth muscle cells, adipose tissue, and vessels. Its morphological diversity often poses diagnostic problems. In this paper, the authors report a peculiar case of epithelioid HAML
Application of second-derivate UV spectrophotometry to the determination of homatropine methylbromide in single-component dosage form.
M Knochen et al.
Bollettino chimico farmaceutico, 126(7), 294-297 (1987-07-01)
Litao Yang et al.
Journal of gastroenterology and hepatology, 28(10), 1648-1653 (2013-06-05)
Hepatic angiomyolipoma (AML) is a rare, hepatic mesenchymal neoplasm. Its preoperative diagnosis is very difficult, and the treatment is still controversial. The aim is to summarize experience in diagnosis and management of hepatic AML from a cancer center. We retrospectively
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service